OXETANE ADVANTAGE - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
77283705
Word Mark
OXETANE ADVANTAGE
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2009-10-14
Filing Date
2007-09-19
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2008-09-02
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
MAYES, LAURIE ANN
Statements
Disclaimer with Predetermined Text
"OXETANE"
Goods and Services
Providing technical advice to customers regarding the use of resins composed of oxetane in stereolithography manufacturing
Classification Information
International Class
40 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2008-06-23
Primary Code
040
First Use Anywhere Date
2006-07-00
First Use In Commerce Date
2006-07-00
Correspondences
Name
LYNN A. SULLIVAN
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2007-09-25 | NEW APPLICATION ENTERED IN TRAM |
2007-12-21 | ASSIGNED TO EXAMINER |
2007-12-21 | NON-FINAL ACTION WRITTEN |
2007-12-26 | NON-FINAL ACTION MAILED |
2008-06-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2008-06-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-06-23 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2008-07-26 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2008-07-28 | ASSIGNED TO LIE |
2008-07-28 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2008-08-13 | NOTICE OF PUBLICATION |
2008-09-02 | PUBLISHED FOR OPPOSITION |
2008-11-25 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2009-02-27 | TEAS STATEMENT OF USE RECEIVED |
2009-03-17 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2009-02-27 | USE AMENDMENT FILED |
2009-03-17 | STATEMENT OF USE PROCESSING COMPLETE |
2009-03-17 | SU - NON-FINAL ACTION - WRITTEN |
2009-03-18 | NON-FINAL ACTION MAILED |
2009-10-14 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2009-10-14 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |